CRBP · Corbus Pharmaceuticals Holdings, Inc.

NasdaqHealthcareBiotechnology

Corbus Pharmaceuticals Holdings Inc Is A Clinical Stage Company Focused On New Therapies In Oncology And Obesity And Is Committed To Helping People Defeat Serious Illness By Bringing Inventive Scientific Approaches To Well-Understood Biological Pathways. The Company'S Development Pipeline Includes; Crb-701, A Next-Generation Antibody-Drug Conjugate (Adc) That Targets The Expression Of Nectin-4 On Cancer Cells To Release A Cytotoxic Payload, Crb-601, An Anti-Integrin Monoclonal Antibody That Blocks The Activation Of Tgf Expressed On Cancer Cells, And Crb-913 A Second-Generation Peripherally Restricted Cb1 Receptor Inverse Agonist Designed To Treat Obesity.

HealthcareNasdaqUSMid Float

FLOAT

16.2M

FREE FLOAT %

87%

SHARES O/S

18.7M

MARKET CAP

$78.3M

EXCHANGE

Nasdaq

COUNTRY

CRBP Catalyst History

No catalysts recorded for CRBP yet

Day Trader Sniper hasn't classified a publishable catalyst for CRBP yet. New events appear here as they're scored.

Be early on the next CRBP spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

CRBP · Corbus Pharmaceuticals Holdings, Inc.

CRBP Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.